GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wife of DS Smith CEO sells 5.6m-pound stake

Wed, 24th Jul 2013 15:53

The wife of DS Smith frontman Miles Roberts sold a substantial sum of shares in the packaging and office supplies firm on the same day it was revealed the Chief Executive Officer (CEO) received a big pay increase last year.The move came on Tuesday, the same day DS Smith released its annual report in which it said the CEO had earned a total of £1.6m for the fiscal year ended April 30th, up from £1.3m the year before. This included an annual salary of £0.61m and bonuses totalling £0.76m, in addition to pension payments and other benefits.Gillian Roberts exercised nil-cost options over nearly 2.6m shares and subsequently sold around 2.22m of them at a price of 250.53p each, making a total of nearly £5.6m.The couple's total holding following the transaction was left at just under 0.6m shares, equal to a 0.064% stake.The stock has risen by over 20% so far in 2013.Top Director BuysBanco Santander SA (BNC) Director name: Mr Emilio BotinAmount purchased: 13,430 @ 420.84p Value: £56,519Banco Santander SA (BNC) Director name: Mr Emilio BotinAmount purchased: 11,084 @ 418.86p Value: £46,426Croda International (CRDA) Director name: Mr Martin FlowerAmount purchased: 2,000 @ 2,424.99p Value: £48,500VP (VP.) Director name: Mr Neil A StothardAmount purchased: 8,500 @ 407.00p Value: £34,595VP (VP.) Director name: Ms Allison BainbridgeAmount purchased: 5,500 @ 408.00p Value: £22,440Banco Santander SA (BNC) Director name: Mr Emilio BotinAmount purchased: 4,000 @ 418.77p Value: £16,751Scientific Digital Imaging (SDI) Director name: Mr Kenneth FordAmount purchased: 100,000 @ 16.50p Value: £16,500Faroe Petroleum (FPM) Director name: Mr Roger WittsAmount purchased: 10,000 @ 111.50p Value: £11,150Top Director SellsSmith (DS) (SMDS) Director name: Mr Miles RobertsAmount sold: 2,218,519 @ 250.53p Value: £5,558,056e-Therapeutics (ETX) Director name: Mr Malcolm YoungAmount sold: 1,230,177 @ 35.50p Value: £436,713SThree (STHR) Director name: Mr Steve QuinnAmount sold: 101,633 @ 335.09p Value: £340,562e-Therapeutics (ETX) Director name: Mr Malcolm YoungAmount sold: 125,059 @ 27.00p Value: £33,766e-Therapeutics (ETX) Director name: Mr Malcolm YoungAmount sold: 50,000 @ 27.00p Value: £13,500BC
More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.